Adherence in Pediatric Multiple Sclerosis

Status:	Recruiting
Conditions:	Neurology, Neurology, Multiple Sclerosis
Therapuetic Areas:	Neurology, Other
Healthy:	No
Age Range:	10 - 18
Updated:	4/2/2016
Start Date:	January 2013
Contact:	Stephanie A Grover, MSc, CCRP
Email:	stephanie.grover@sickkids.ca
Phone:	416-813-7654

Treatment Adherence in Pediatric Multiple Sclerosis

Disease modifying therapies (DMT) are widely used for children and adolescents with MS.
Nonetheless, many pediatric patients continue to relapse and therefore require changes in
therapy. We designed this research study to learn more about medication use in children and
adolescents with MS. We are also interested in learning what a behavioral feedback
intervention can tell us about adherence to medicine. Finally, we hope this research project
will inform the way we provide clinical care for children and adolescents with MS.

Inclusion Criteria:

- Adolescent boys/girls who are 10 to 17 years 11 months old;

- Have a diagnosis of MS, as per revised McDonald diagnostic criteria and International
Pediatric MS Study Group criteria;

- Prescribed with an oral or injectable disease-modifying therapy for MS for at least
six months.

Exclusion Criteria:

- Have non-specific white matter abnormalities and metabolic or infectious etiologies
for white matter abnormalities. This is indicative of not having a true diagnosis of
MS.

- Patients on IV DMT will not be included in the study.

- Non-English speaking patients

We found this trial at

sites

Washington University

1 Brookings Drive
St. Louis, Missouri 63110

(314) 935-5000